“The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN”. Vascular and Endovascular Review 8, no. 5s (November 1, 2025): 154–161. Accessed February 5, 2026. https://verjournal.com/index.php/ver/article/view/448.